Download PDF
Dtsch Med Wochenschr 2004; 129(41): 2183-2186
DOI: 10.1055/s-2004-831862
Aktuelle Diagnostik & Therapie
Kardiologie
© Georg Thieme Verlag Stuttgart · New York

Kardiomyopathien und Magnetresonanztomographie

Cardiomyopathies and magnetic resonance imagingJ. Schulz-Menger1
  • 1Abteilung Kardiologie, Franz Volhard Klinik, Charité Campus Buch, Helios-Klinikum Berlin
Further Information

Publication History

eingereicht: 7.6.2004

akzeptiert: 21.9.2004

Publication Date:
30 September 2004 (online)

Also available at
    Permissions and Reprints

Die kardiale Magnetresonanztomographie (MRT) stößt durch ihre Möglichkeit, Gewebe und Funktion zu charakterisieren, zunehmend auf Interesse in der Kardiologie und somit auch bei der Diagnostik der unterschiedlichen Kardiomyopathieformen.

Literatur

  • 1 Arcasoy S M, Christie J D, Pochettino A. et al . Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation.  Chest. 2001;  120 873-880
    Google Scholar
  • 2 Barkhausen J, Ebert W, Debatin J F, Weinmann H J. Imaging of myocardial infarction: comparison of magnevist and gadophrin-3 in rabbits.  J Am Coll Cardiol. 2002;  39 1392-1398
    Google Scholar
  • 3 Bellenger N G, Davies L C, Francis J M, Coats A J, Pennell D J. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.  J Cardiovasc Magn Reson. 2000;  2 271-278
    Google Scholar
  • 4 Breen J F. Imaging of the pericardium.  J Thorac Imaging. 2001;  16 47-54
    Google Scholar
  • 5 Dymarkowski S, Ni Y, Miao Y, Bogaert J, Rademakers F, Bosmans H, Marchal G. Value of t2-weighted magnetic resonance imaging early after myocardial infarction in dogs: comparison with bis-gadolinium-mesoporphyrin enhanced T1-weighted magnetic resonance imaging and functional data from cine magnetic resonance imaging.  Invest Radiol. 2002;  37 77-85
    Google Scholar
  • 6 Friedrich M G, Strohm O, Schulz Menger J, Marciniak H, Luft F C, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis.  Circulation. 1998;  97 1802-1809
    Google Scholar
  • 7 Gagliardi M, Poletta B, Di Renzi P. MRI for the diagnosis and follow up of myocarditis (letter).  Circulation. 1999;  99 458-459
    Google Scholar
  • 8 Keller D I, Osswald S, Bremerich J. et al . Arrhythmogenic right ventricular cardiomyopathy: diagnostic and prognostic value of the cardiac MRI in relation to arrhyzmia-free survival.  Int J Cardiovascular Imaging. 2003;  19 537-543
    Google Scholar
  • 9 Mahrholdt H, Goedecke C, Wagner A. et al . Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology.  Circulation. 2004;  109 1250-1258
    Google Scholar
  • 10 Maisch B, Seferovic P M, Ristic A D. et al . Guidelines on the diagnosis and management of pericardial diseases executive summary: The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology.  Eur Heart J. 2004;  25 587-610
    Google Scholar
  • 11 McCrohon J A, Moon J C, Prasad S K. et al . Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.  Circulation. 2003;  108 54-59
    Google Scholar
  • 12 McKenna W J, Thiene G, Nava A. et al . Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.  Br Heart J. 1994;  71 215-218
    Google Scholar
  • 13 Moon J C, McKenna W J, McCrohon J A. et al . Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.  J Am Coll Cardiol. 2003;  41 1561-1567
    Google Scholar
  • 14 Pons Llado G, Carreras F, Borras X, Palmer J, Llauger J, Bayes de Luna A. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging.  Am-J-Cardiol,. 1997;  79 1651-1656
    Google Scholar
  • 15 Schulz-Menger J, Strohm O, Dietz R, Friedrich M G. Visualization of cardiac involvement in patients with systemic sarcoidosis applying contrast-enhanced magnetic resonance imaging.  Magma. 2000;  11 82-83
    Google Scholar
  • 16 Schulz-Menger J, Strohm O, Waigand J, Uhlich F, Dietz R, Friedrich M G. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization.  Circulation. 2000;  101 1764-1766
    Google Scholar
  • 17 Shimada T, Shimada K, Sakane T. et al . Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.  Am J Med. 2001;  110 520-527
    Google Scholar
  • 18 Smith W H, Beacock D J, Goddard A J, Bloomer T N, Ridgway J P, Sivananthan U M. Magnetic resonance evaluation of the pericardium.  Br J Radiol. 2001;  74 384-392
    Google Scholar
  • 19 Strohm O, Schulz-Menger J, Pilz B, Osterziel K J, Dietz R, Friedrich M G. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy.  J Magn Reson Imaging. 2001;  13 367-371
    Google Scholar
  • 20 Suzuki J, Shimamato R, Nishikawa J. et al . Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging.  J Am Coll Cardiol. 1999;  33 146-151
    Google Scholar

Dr. Jeanette Schulz-Menger

Franz-Volhard-Klinik

Wiltbergstraße 50

13125 Berlin

Phone: 030/94172593

Fax: 030/9492560

Email: schulzmenger@fvk-berlin.de

      >